Interesting facts
Interesting Facts about N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide
N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide is a fascinating compound with several noteworthy features:
- Complex Structure: This compound showcases the intricate interplay of various functional groups, combining sulfamoyl, carbamoyl, and pyrazine moieties. Such diversity often leads to unique properties that can be useful in pharmaceutical applications.
- Therapeutic Potential: Compounds with similar structures are often explored for their potential as drugs. The presence of the sulfamoyl group suggests possible activity against bacterial infections or even cancer pathways, making understanding this compound crucial in medicinal chemistry.
- Application in Drug Design: The alloying of the phenyl ring with a cyclohexyl substituent may enhance the lipophilicity of the compound, which is an essential characteristic for crossing cell membranes in drug action.
- Research Significance: Such a chemical architecture invites extensive research to elucidate its mechanisms of action, biological activity, and potential therapeutic applications.
- Environmental Impact: Studying compounds like this one can also provide insight into the safety and environmental interactions of synthesized organic compounds.
As scientists delve into the world of complex organic molecules, compounds like N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide become essential in paving the way for innovative solutions in medicine and beyond. As one renowned chemist once said, "The beauty of chemistry lies in its complexity - each molecule tells a unique story."
Synonyms
glipizide
29094-61-9
Glucotrol
Glydiazinamide
Dipazide
Glibenese
Glucozide
Glupizide
Melizide
Minodiab
Napizide
Sucrazide
Mindiab
Glucotrol XL
Glibetin
Glidiab
Glucolip
Glupitel
Minidab
Minidiab
Aldiab
Digrin
Glican
Glipid
Glyde
Ozidia
Gluco-Rite
Glipizida
Glipizidum
Glipizidum [INN-Latin]
Glipizida [INN-Spanish]
K 4024
CP 28720
CP-28720
K-4024
N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-5-methylpyrazine-2-carboxamide
TK 1320
CP 28,720
Glipizide slow release
MFCD00072159
CP-28,720
UNII-X7WDT95N5C
EINECS 249-427-6
X7WDT95N5C
1-Cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)urea
NSC-759120
BRN 0903495
N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide
CHEBI:5384
DTXSID0040676
Glidiazinamide
Glypidizine
Pyrazinecarboxamide, N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl-
Glide
CHEMBL1073
MLS000069386
N-(4-(beta-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea
CP 28720;K 4024
DTXCID8020676
Glipizide [USAN:USP:INN:BAN]
METAGLIP COMPONENT GLIPIZIDE
Urea, 1-cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)-
N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide
N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide
NSC 759120
NCGC00015462-07
SMR000058455
Glipizidum (INN-Latin)
CAS-29094-61-9
Glipizida (INN-Spanish)
GLIPIZIDE (MART.)
GLIPIZIDE [MART.]
1-cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl]sulfonyl]urea
1-Cyclohexyl-3-{4-[2-(5-methylpyrazine-2-carboxamido)ethyl]phenylsulfonyl}urea
GLIPIZIDE (USP-RS)
GLIPIZIDE [USP-RS]
GLIPIZIDE (EP MONOGRAPH)
GLIPIZIDE [EP MONOGRAPH]
GLIPIZIDE (USP MONOGRAPH)
GLIPIZIDE [USP MONOGRAPH]
Glipizide (USAN:USP:INN:BAN)
1-cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea
N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-N'-cyclohexylurea
Glucotrol (TN)
Pyrazinecarboxamide, N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-
Glipizide (USP/INN)
SR-01000000010
Glipizideer
GlipizideXL
GlucotrolXL
GlipizideERER
Glipizide ER
Glipizide XL
Glipizide, solid
N-(2-(4-((cyclohexylcarbamoyl)sulfamoyl)phenyl)ethyl)-5-methylpyrazine-2-carboxamide
N-[4-[N-(Cyclohexylcarbamoyl)sulfamoyl]phenethyl]-5-methylpyrazine-2-carboxamide
glipizide/glucotrol
Glipizide,(S)
N-[2-[4[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methylpyrazinecarboxamide; 1-Cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)
Prestwick_242
Glipizide (Standard)
KS-1068
Metaglip (Salt/Mix)
Glipizide (Glucotrol)
GLIPIZIDE [INN]
GLIPIZIDE [JAN]
GLIPIZIDE [MI]
Lopac-G-117
GLIPIZIDE [USAN]
Opera_ID_1908
Prestwick0_000131
Prestwick1_000131
Prestwick2_000131
Prestwick3_000131
GLIPIZIDE [VANDF]
G-117
GLIPIZIDE [WHO-DD]
CBiol_001788
Lopac0_000621
SCHEMBL17094
BSPBio_000202
BSPBio_001349
KBioGR_000069
KBioSS_000069
MLS001148176
BIDD:GT0476
SPBio_002141
BPBio1_000224
GTPL6821
GLIPIZIDE [ORANGE BOOK]
HY-B0254R
KBio2_000069
KBio2_002637
KBio2_005205
KBio3_000137
KBio3_000138
Bio1_000074
Bio1_000563
Bio1_001052
Bio2_000069
Bio2_000549
GLXC-20257
HMS1361D11
HMS1568K04
HMS1791D11
HMS1989D11
HMS2089C21
HMS2093J09
HMS2095K04
HMS2233N11
HMS3259K12
HMS3261N04
HMS3369L12
HMS3402D11
HMS3655G04
HMS3712K04
Pharmakon1600-01505433
BCP09195
HY-B0254
PXB42607
Tox21_110156
Tox21_301834
Tox21_500621
BBL028143
BDBM50012956
NSC759120
NSC813218
s1715
STK631952
AKOS005564405
GLIPIZIDE COMPONENT OF METAGLIP
N-[4-(3-Cyclohexylureidosulfonyl)phenethyl]-5-methyl-2-pyrazinecarboxamide
Tox21_110156_1
CCG-204710
DB01067
FG01273
LP00621
NC00564
NSC-813218
SDCCGSBI-0050603.P003
IDI1_033819
Glipizide 100 microg/mL in Acetonitrile
NCGC00015462-01
NCGC00015462-02
NCGC00015462-03
NCGC00015462-04
NCGC00015462-05
NCGC00015462-06
NCGC00015462-08
NCGC00015462-09
NCGC00015462-10
NCGC00015462-11
NCGC00015462-12
NCGC00015462-14
NCGC00015462-23
NCGC00016802-01
NCGC00023748-03
NCGC00023748-04
NCGC00023748-05
NCGC00023748-06
NCGC00023748-07
NCGC00255522-01
NCGC00261306-01
2-Pyrazinecarboxamide, N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-
AC-15789
SY009252
SBI-0050603.P002
EU-0100621
G0369
NS00009815
SW196549-3
D00335
Q3108899
SR-01000000010-2
SR-01000000010-5
BRD-K12219985-001-04-8
BRD-K12219985-001-15-4
BRD-K12219985-001-25-3
BRD-K12219985-001-26-1
Z1575081877
Glipizide, European Pharmacopoeia (EP) Reference Standard
Glipizide, United States Pharmacopeia (USP) Reference Standard
Glipizide, Pharmaceutical Secondary Standard; Certified Reference Material
1-cyclohexyl-3-(4-(2-(2-methylpyrazine-5-carboxamido)ethyl)phenylsulfonyl)urea
1-Cyclohexyl-3-{{p=[2-[5-methylpyrazine-carboxamido)-ethyl]phenyl}sulphonyl}urea
N-(4-(.beta.-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea
172964-66-8
249-427-6
N-(2-[4-(([(Cyclohexylamino)carbonyl]amino)sulfonyl)phenyl]ethyl)-5-methyl-2-pyrazinecarboxamide
Solubility of N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide
The solubility of the compound N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide (C17H14F3N3O2S) is influenced by several key factors:
In conclusion, while the solubility of N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide can be favorable in polar and non-polar solvents alike, it is crucial to test it experimentally under various conditions for precise characterization. Abstractly, one might say, "Solubility is a reflection of molecular interactions and environmental conditions."